Evidence map›Paper›PMID 36422867›Full record

ArticleJMIR rehabilitation and assistive technologies2022

Systematic Development of the ReWin Application: A Digital Therapeutic Rehabilitation Innovation for People With Stroke-related Disabilities in India.

Sureshkumar Kamalakannan, Vijay Karunakaran, Ashwin Balaji Kaliappan, Ramakumar Nagarajan

Open access · goldAbstract read
In one paragraph

Article in JMIR rehabilitation and assistive technologies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Digital therapeutics in the clinic.Bioengineering & translational medicine · 2023
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Sureshkumar Kamalakannan *Department of Social Work Education and Community Wellbeing, Faculty of Health and Life Sciences, Northumbria University, Newcastle Upon Tyne, United Kingdom.ORCID https://orcid.org/0000-0001-6970-4952
Vijay Karunakaran *Department of mHealth Design and Development, InGage Technologies Pvt, Ltd, Chennai, India.ORCID https://orcid.org/0000-0003-3228-4565
Ashwin Balaji Kaliappan *Department of mHealth Design and Development, InGage Technologies Pvt, Ltd, Chennai, India.ORCID https://orcid.org/0000-0002-4138-4632
Ramakumar Nagarajan *Neurological Rehabilitation Department, Chennai Advanced Rehabilitation Centre, Chennai, India.ORCID https://orcid.org/0000-0003-0412-8442
Northumbria University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is a viewpoint paper that aims to describe the systematic approach to the development of a technology-driven stroke rehabilitation innovation to manage disabilities following a stroke at home in India. This paper intends to sensitize public health innovators and intervention development experts about the important aspects that need to be considered to develop a culturally sensitive, patient-centered, scalable solution for stroke care using technology. Stroke has been the second-leading cause of death and the third-leading cause of disability globally for the past 3 decades. The emerging technological innovations for stroke care were predominantly designed and developed by digital technology experts as stand-alone products with very minimal efforts to explore their feasibility, acceptability, and, more importantly, scalability. Hence, a digital therapeutic rehabilitation innovation for people with stroke-related disabilities in India was systematically developed and is being evaluated. ReWin is an innovation that is technologically driven and envisions digital therapeutics as a medium for the provision of rehabilitation to persons with disabilities. It is conceptualized and developed based on the International Classification of Functioning, Disability and Health. ReWin encompasses specific technological aspects to enable its scientific framework and conceptualization to suit the context and needs of stroke care providers and consumers. The framework is built with 2 separate applications, one for the providers and one for the patients and caregivers. Each of these applications has a specific inbuilt design to add data about the demographic details of the user, stroke severity using the National Institute of Health Stroke Scale, and self-assessment of disability measured by the modified Barthel Index. Users can communicate with each other and decide on their therapeutic goals, therapy training information, and progress remotely from where they are. The ultimate outcome expected from the ReWin innovation is a continuum of care for stroke survivors that is effective, safe, and of good quality. Systematic development cannot make the intervention scalable. The intervention needs to be evaluated for its feasibility, acceptability, and effectiveness. Currently, ReWin is being evaluated for its feasibility and acceptability. The evaluation of ReWin will provide an opportunity to develop a scalable solution for empowering therapists and persons with disabilities, in general, to objectively self-manage their treatment. Findings from this study will also provide valuable information about the resources required to deliver such interventions in resource-constrained settings like India.

Indexed as

acceptabilitydigital technologydigital therapydisabilityfeasibilityIndianeurological rehabilitationpatient carerecoveryrehabilitationstrokestroke caretelerehabilitation

Identifiers

PMID36422867
PMCPMC9732759
OpenAlexW4310336085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.